Anti-APP

Anti-APP Antibody was affinity purified from monospecific antiserum by immunoaffinity purification. A BLAST analysis was used to suggest cross-reactivity with APP with Human, Mouse and Rat based on 100% homology with the immunizing sequence. Cross-reactivity with APP from other sources has not been determined. APP antibody detects the human amyloid A4 protein. Accumulation of the amyloid-beta peptide (Abeta) in the cerebral cortex is a critical event in the pathogenesis of Alzheimer's disease. The beta-amyloid protein precursor (APP) is cleaved by beta-secretase, producing a soluble derivative of the protein and a membrane anchored 99-amino acid carboxy-terminal fragment (C99). The C99 fragment serves as substrate for gamma-secretase to generate the 4 kDa amyloid-beta peptide (Abeta), which is deposited in the brains of all suffers of Alzheimer's disease. Anti-APP is ideal for investigators that are involved in Neuroscience research.